Nomura Asset Management Co. Ltd. Has $33.94 Million Holding in Waters Co. (NYSE:WAT)

Nomura Asset Management Co. Ltd. Has $33.94 Million Holding in Waters Co. (NYSE:WAT)

Nomura Asset Management Co. Ltd. trimmed its position in Waters Co. (NYSE:WAT) by 51.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 174,332 shares of the medical instruments supplier’s stock after selling 186,239 shares during the period. Nomura Asset Management Co. Ltd. owned 0.23% of Waters worth $33,939,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Marshall Wace LLP purchased a new position in Waters during the 2nd quarter worth $239,000. Wells Fargo & Company MN grew its stake in Waters by 40.5% during the 2nd quarter. Wells Fargo & Company MN now owns 336,181 shares of the medical instruments supplier’s stock worth $65,081,000 after buying an additional 96,866 shares during the last quarter. Fundsmith Equity Fund L.P. purchased a new position in Waters during the 2nd quarter worth $915,485,000. Ontario Teachers Pension Plan Board grew its stake in Waters by 62.9% during the 2nd quarter. Ontario Teachers Pension Plan Board now owns 155,990 shares of the medical instruments supplier’s stock worth $30,198,000 after buying an additional 60,239 shares during the last quarter. Finally, Mackay Shields LLC grew its stake in Waters by 50.2% during the 2nd quarter. Mackay Shields LLC now owns 20,112 shares of the medical instruments supplier’s stock worth $3,894,000 after buying an additional 6,724 shares during the last quarter. 98.51% of the stock is currently owned by hedge funds and other institutional investors.

Several analysts have weighed in on the company. Goldman Sachs Group downgraded Waters from a “neutral” rating to a “sell” rating and dropped their price target for the company from $185.00 to $180.00 in a research note on Friday, November 30th. ValuEngine upgraded Waters from a “hold” rating to a “buy” rating in a research note on Tuesday, November 27th. UBS Group dropped their price target on Waters from $210.00 to $200.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 24th. Barclays dropped their price target on Waters from $200.00 to $190.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 24th. Finally, JPMorgan Chase & Co. lowered their target price on Waters from $200.00 to $185.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 24th. Three equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have given a buy rating to the company’s stock. Waters currently has a consensus rating of “Hold” and a consensus price target of $205.07.

In other news, Director Thomas P. Salice sold 3,500 shares of the company’s stock in a transaction that occurred on Wednesday, October 31st. The stock was sold at an average price of $192.00, for a total value of $672,000.00. Following the completion of the sale, the director now directly owns 20,911 shares in the company, valued at $4,014,912. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Christopher A. Kuebler sold 8,000 shares of the company’s stock in a transaction that occurred on Friday, November 16th. The shares were sold at an average price of $199.67, for a total value of $1,597,360.00. Following the completion of the sale, the director now owns 18,911 shares of the company’s stock, valued at $3,775,959.37. The disclosure for this sale can be found here. 0.98% of the stock is owned by corporate insiders.

Shares of Waters stock traded down $6.06 during mid-day trading on Wednesday, reaching $195.45. 656,398 shares of the stock traded hands, compared to its average volume of 507,708. Waters Co. has a fifty-two week low of $167.93 and a fifty-two week high of $220.20. The stock has a market capitalization of $15.04 billion, a P/E ratio of 26.09, a PEG ratio of 2.41 and a beta of 0.97. The company has a debt-to-equity ratio of 0.61, a current ratio of 6.63 and a quick ratio of 5.93.

Waters (NYSE:WAT) last announced its earnings results on Tuesday, October 23rd. The medical instruments supplier reported $1.92 EPS for the quarter, beating analysts’ consensus estimates of $1.90 by $0.02. Waters had a return on equity of 30.68% and a net margin of 2.32%. The business had revenue of $578.02 million during the quarter, compared to analysts’ expectations of $587.43 million. During the same quarter in the prior year, the firm earned $1.77 earnings per share. The business’s revenue was up 2.2% compared to the same quarter last year. As a group, research analysts anticipate that Waters Co. will post 8.05 EPS for the current fiscal year.

Waters Company Profile

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in the United States, Europe, Asia, and internationally. It designs, manufactures, sells, and services high and ultra performance liquid chromatography technology, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Recommended Story: How dollar cost averaging works

Related posts

Leave a Comment